Globus Medical Schedules Second Quarter Earnings Release and Conference Call
13 Julho 2023 - 5:30PM
Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal
solutions company, will announce its financial results for the
second quarter ended June 30, 2023 after the market close on
Thursday, August 3, 2023. A copy of the release will be
available on the Globus Medical website at
www.investors.globusmedical.com.
Following the announcement, Globus Medical will hold a
teleconference to discuss its performance with the investment
community at 4:30 p.m. Eastern Time. Participants may access the
conference call live via webcast on the Investors page of Globus
Medical’s website at
https://www.investors.globusmedical.com/news-events/events-webcasts.
To participate via telephone, please register in advance at this
link. Upon registration, all telephone participants will receive a
confirmation email detailing how to join the conference call,
including the dial-in number along with a unique passcode and
registrant ID that can be used to access the call.
The audio archive will be available after the call on the
Investor page of the Globus Medical website.
About Globus Medical, Inc.Globus Medical, Inc.
is a leading musculoskeletal solutions company based in Audubon,
PA. The company was founded in 2003 by an experienced team of
professionals with a shared vision to create products that enable
surgeons to promote healing in patients with musculoskeletal
disorders. Additional information can be accessed at
www.globusmedical.com.
Safe Harbor StatementsAll statements included
in this press release other than statements of historical fact are
forward-looking statements and may be identified by their use of
words such as “believe,” “may,” “might,” “could,” “will,” “aim,”
“estimate,” “continue,” “anticipate,” “intend,” “expect,” “plan”
and other similar terms. These forward-looking statements are based
on our current assumptions, expectations and estimates of future
events and trends. Forward-looking statements are only predictions
and are subject to many risks, uncertainties and other factors that
may affect our businesses and operations and could cause actual
results to differ materially from those predicted. These risks and
uncertainties include, but are not limited to, health epidemics,
pandemics and similar outbreaks, including the COVID-19 pandemic,
factors affecting our quarterly results, our ability to manage our
growth, our ability to sustain our profitability, demand for our
products, our ability to compete successfully (including without
limitation our ability to convince surgeons to use our products and
our ability to attract and retain sales and other personnel), our
ability to rapidly develop and introduce new products, our ability
to develop and execute on successful business strategies, our
ability to comply with laws and regulations that are or may become
applicable to our businesses, our ability to safeguard our
intellectual property, our success in defending legal proceedings
brought against us, trends in the medical device industry, general
economic conditions, and other risks. For a discussion of these and
other risks, uncertainties and other factors that could affect our
results, you should refer to the disclosure contained in our most
recent annual report on Form 10-K filed with the U.S. Securities
and Exchange Commission, including the sections labeled “Risk
Factors” and “Cautionary Note Concerning Forward-Looking
Statements,” and in our Forms 10-Q, Forms 8-K and other filings
with the U.S. Securities and Exchange Commission. These documents
are available at www.sec.gov. Moreover, we operate in an evolving
environment. New risk factors and uncertainties emerge from time to
time and it is not possible for us to predict all risk factors and
uncertainties, nor can we assess the impact of all factors on our
business or the extent to which any factor, or combination of
factors, may cause actual results to differ materially from those
contained in any forward-looking statements. Given these risks and
uncertainties, readers are cautioned not to place undue reliance on
any forward-looking statements. Forward-looking statements
contained in this press release speak only as of the date of this
press release. We undertake no obligation to update any
forward-looking statements as a result of new information, events
or circumstances or other factors arising or coming to our
attention after the date hereof.
Contact:Brian KearnsSenior Vice President,
Business Development and Investor RelationsPhone: (610)
930-1800Email: investors@globusmedical.comwww.globusmedical.com
Globus Medical (NYSE:GMED)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024
Globus Medical (NYSE:GMED)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024